• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.

作者信息

Regelink Josien C, van Roessel Cinthy H M, van Galen Karin P M, Ossenkoppele Gert J, Huijgens Peter C, Zweegman Sonja

出版信息

J Clin Oncol. 2010 Dec 10;28(35):e741-3; author reply e744-5. doi: 10.1200/JCO.2010.31.5515. Epub 2010 Nov 8.

DOI:10.1200/JCO.2010.31.5515
PMID:21060027
Abstract
摘要

相似文献

1
Long-term follow-up of tandem autologous stem-cell transplantation in multiple myeloma.多发性骨髓瘤串联自体干细胞移植的长期随访
J Clin Oncol. 2010 Dec 10;28(35):e741-3; author reply e744-5. doi: 10.1200/JCO.2010.31.5515. Epub 2010 Nov 8.
2
Re: Tandem vs single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis.关于：串联自体造血细胞移植与单次自体造血细胞移植治疗多发性骨髓瘤的系统评价和荟萃分析
J Natl Cancer Inst. 2009 Oct 21;101(20):1430-1; author reply 1431-3. doi: 10.1093/jnci/djp320. Epub 2009 Sep 30.
3
Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.在自体造血干细胞移植失败后，使用氟达拉滨和马法兰进行减低剂量预处理进行第二次造血干细胞移植的可行性。
Transplant Proc. 2010 Nov;42(9):3723-8. doi: 10.1016/j.transproceed.2010.09.005.
4
Tandem bone marrow transplantation in multiple myeloma.多发性骨髓瘤的串联骨髓移植
N Engl J Med. 2004 Apr 1;350(14):1466-7; author reply 1466-7.
5
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myeloma.米托蒽醌持续输注联合马法兰推注作为多发性骨髓瘤的干细胞移植预处理方案。
Cancer Invest. 2011 Mar;29(3):214-9. doi: 10.3109/07357907.2010.550663.
6
Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.多发性骨髓瘤移植中的争议：序贯自体移植和小型同种异体移植
Bone Marrow Transplant. 2001 Oct;28(8):725-35. doi: 10.1038/sj.bmt.1703254.
7
Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.多发性骨髓瘤清髓性异基因干细胞移植的长期疗效
Biol Blood Marrow Transplant. 2007 Aug;13(8):925-31. doi: 10.1016/j.bbmt.2007.04.006. Epub 2007 May 29.
8
Long-term follow-up of an intensified myeloablative conditioning regimen with in vivo T cell depletion followed by allografting in patients with advanced multiple myeloma.强化清髓性预处理方案联合体内 T 细胞耗竭后异基因造血干细胞移植治疗晚期多发性骨髓瘤的长期随访。
Biol Blood Marrow Transplant. 2010 Jun;16(6):861-4. doi: 10.1016/j.bbmt.2010.01.018. Epub 2010 Feb 6.
9
Abnormal protein bands in patients with multiple myeloma after haematopoietic stem cell transplantation: does it have a prognostic significance?造血干细胞移植后多发性骨髓瘤患者的异常蛋白带：是否具有预后意义？
Hematol Oncol. 2010 Dec;28(4):180-4. doi: 10.1002/hon.936.
10
International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.国际骨髓瘤工作组关于异体干细胞移植治疗多发性骨髓瘤现状的共识声明。
J Clin Oncol. 2010 Oct 10;28(29):4521-30. doi: 10.1200/JCO.2010.29.7929. Epub 2010 Aug 9.

引用本文的文献

1
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.来那度胺、硼替佐米和地塞米松联合依鲁替尼或伊沙妥昔单抗治疗初诊多发性骨髓瘤患者后的干细胞采集：来自 GMMG-HD6 和 -HD7 试验的单中心经验。
BMC Cancer. 2023 Nov 21;23(1):1132. doi: 10.1186/s12885-023-11507-9.
2
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.达雷妥尤单抗、硼替佐米、沙利度胺和地塞米松方案与硼替佐米、环磷酰胺和地塞米松方案用于新诊断多发性骨髓瘤患者自体干细胞采集的比较
Transfus Med Hemother. 2023 Mar 24;50(5):371-381. doi: 10.1159/000529691. eCollection 2023 Oct.
3
Impact of Clinical Parameters and Induction Regimens on Peripheral Blood Stem-Cell Mobilization and Collection in Multiple Myeloma Patients.临床参数和诱导方案对多发性骨髓瘤患者外周血干细胞动员及采集的影响
Transfus Med Hemother. 2023 Jun 5;50(5):382-395. doi: 10.1159/000530056. eCollection 2023 Oct.
4
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.低剂量外周血造血干细胞移植后高剂量化疗 - 造血重建的评估。
BMC Cancer. 2020 Apr 25;20(1):353. doi: 10.1186/s12885-020-06873-7.
5
High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting.门诊环境下多发性骨髓瘤患者的大剂量化疗及自体干细胞移植
BMC Cancer. 2017 Feb 22;17(1):151. doi: 10.1186/s12885-017-3137-4.
6
Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities.造血干细胞移植作为骨髓瘤的一线治疗：当前概念与未来可能性的全球视角
Oncol Rev. 2012 Oct 4;6(2):e14. doi: 10.4081/oncol.2012.e14. eCollection 2012 Oct 2.
7
Utilization of stored autologous PBSCs to support second autologous transplantation in multiple myeloma patients in the era of novel agent therapy.在新型药物治疗时代，利用储存的自体外周血干细胞支持多发性骨髓瘤患者进行第二次自体移植。
Bone Marrow Transplant. 2015 May;50(5):663-7. doi: 10.1038/bmt.2015.13. Epub 2015 Mar 2.
8
Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012.多发性骨髓瘤治疗的诊断与管理指南：巴西血液学、血液疗法及细胞治疗协会项目指南：巴西医学协会 - 2012年版
Rev Bras Hematol Hemoter. 2013;35(3):201-17. doi: 10.5581/1516-8484.20130050.
9
Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphoma.自体干细胞移植在复发和难治性霍奇金淋巴瘤中的现状。
Oncologist. 2012;17(1):80-90. doi: 10.1634/theoncologist.2011-0177. Epub 2011 Dec 30.
10
Treatment of multiple myeloma.多发性骨髓瘤的治疗。
Nat Rev Clin Oncol. 2011 Apr 26;8(8):479-91. doi: 10.1038/nrclinonc.2011.63.